Page 63 - GPD-2-3

Gene & Protein in Disease SARS-CoV-2 Omicron variants in Iraq

https://doi.org/10.1371/journal.ppat.1010260 https://doi.org/10.1038/s41467-021-21118-2
50. Tian D, Sun Y, Zhou J, et al., 2021, The global epidemic of 54. Lubinski B, Fernandes MHV, Frazier L, et al., 2022,
the SARS-CoV-2 Delta variant, key spike mutations and Functional evaluation of the P681H mutation on the
immune escape. Front Immunol, 12: 751778. proteolytic activation of the SARS-CoV-2 variant B.1.1.7
https://doi.org/10.3389/fimmu.2021.751778 (Alpha) spike. iScience, 25: 103589.
51. Jackson CB, Zhang L, Farzan M, et al., 2021, Functional 55. Saito A, Irie T, Suzuki R, et al., 2022, Enhanced fusogenicity
importance of the D614G mutation in the SARS-CoV-2 and pathogenicity of SARS-CoV-2 Delta P681R mutation.
spike protein. Biochem Biophys Res Commun, 538: 108–115. Nature, 602: 300–306.
https://doi.org/10.1016/j.bbrc.2020.11.026 https://doi.org/10.1038/s41586-021-04266-9
52. Wang C, Zheng Y, Niu Z, 2021, The virological impacts of 56. Xia S, Liu M, Wang C, et al., 2020, Inhibition of SARS-CoV-2
SARS-CoV-2 D614G mutation. J Mol Cell Biol, 13: 712–720. (previously 2019-nCoV) infection by a highly potent pan-
https://doi.org/10.1093/jmcb/mjab045 coronavirus fusion inhibitor targeting its spike protein that
harbors a high capacity to mediate membrane fusion. Cell
53. Ozono S, Zhang Y, Ode H, et al., 2021, SARS-CoV-2 D614G Res, 30: 343–355.
spike mutation increases entry efficiency with enhanced
ACE2-binding affinity. Nat Commun, 12: 848. https://doi.org/10.1038/s41422-020-0305-x

Volume 2 Issue 3 (2023) 10 https://doi.org/10.36922/gpd.1646